Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
about
Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model.PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence.Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutationAlterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher diseaseProbing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and AmpakinesNonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.Network organization of the huntingtin proteomic interactome in mammalian brain.The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay.Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation.Mitochondria in neuroplasticity and neurological disorders.Polyglutamine toxicity in non-neuronal cells.Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases.Central GABAA receptors are involved in inflammatory and cardiovascular consequences of endotoxemia in conscious rats.Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.Stereochemical Control of Enzymatic Carbon-Carbon Bond-Forming Michael-Type Additions by "Substrate Engineering".Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective
P2860
Q24631610-9BD63C37-48CF-4C70-BB92-8564C0CD2FF3Q27005950-1D015810-DB09-4F88-90A2-EE9EB9D68669Q27314860-1D673176-E2F7-4E26-8868-868CCFFFC887Q28567753-D99EEC0C-7A8B-4CDA-9856-A6C3037DB4F7Q28728849-5368D061-A5FC-41E7-9048-1BC0CC06A744Q30490632-E2C077AF-F605-4CBE-90BB-9C9FFB08C9B2Q33478327-DEECA363-1FD8-4BD2-B64B-7D82377B1798Q33571914-90F21930-1ABD-4BDF-9009-31AB617798FBQ33705003-0F3784F6-BF99-443E-A10F-4ADA92FFAB82Q33713689-AE6A545B-EE7F-4F4B-88CE-AE272360082AQ33812932-E0EFCCBC-6174-472E-A596-6761F2D12D28Q34287971-910CB496-D0EC-4430-8191-2672393B2E73Q35542836-E551130C-D73B-4CBB-82AC-820F53D522DBQ35880053-5DC33749-0444-4708-B1CF-2EC2E8A96CA0Q36206178-64240CAE-A071-4D44-B0D9-6EE23EC886C8Q37216404-9136F1B7-22BB-488C-B0FB-58EF6A5777D2Q37709833-C4E42EBC-C601-494C-AB40-6BFD1FDBE1B0Q38972042-A2F9C0D3-14AA-4BC5-B96A-96ED7FD2F7B3Q40190752-50FB5DF3-2D4C-4571-9585-B2A62A4DC093Q41669344-D96FD523-1006-4F23-8A19-28A0C271F22BQ42366816-C86C6210-711C-4C30-BDA7-A470BEB8D758Q58750861-7CC17440-08B5-4988-9EF9-4857B9C3502F
P2860
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tiagabine is neuroprotective i ...... models of Huntington's disease
@ast
Tiagabine is neuroprotective i ...... models of Huntington's disease
@en
Tiagabine is neuroprotective i ...... odels of Huntington's disease.
@nl
type
label
Tiagabine is neuroprotective i ...... models of Huntington's disease
@ast
Tiagabine is neuroprotective i ...... models of Huntington's disease
@en
Tiagabine is neuroprotective i ...... odels of Huntington's disease.
@nl
prefLabel
Tiagabine is neuroprotective i ...... models of Huntington's disease
@ast
Tiagabine is neuroprotective i ...... models of Huntington's disease
@en
Tiagabine is neuroprotective i ...... odels of Huntington's disease.
@nl
P2093
P2860
P1476
Tiagabine is neuroprotective i ...... models of Huntington's disease
@en
P2093
Mali Jiang
Naoki Masuda
Wenfei Wang
Wenzhen Duan
Xiaofang Wang
Yideng Liang
P2860
P304
P356
10.1016/J.NBD.2008.01.014
P577
2008-03-10T00:00:00Z